154 related articles for article (PubMed ID: 36359738)
1. Single Cell Analysis of Gastric Cancer Reveals Non-Defined Telomere Maintenance Mechanism.
Sung JY; Cheong JH
Cells; 2022 Oct; 11(21):. PubMed ID: 36359738
[TBL] [Abstract][Full Text] [Related]
2. NR4A1-induced increase in the sensitivity of a human gastric cancer line to TNFα-mediated apoptosis is associated with the inhibition of JNK/Parkin-dependent mitophagy.
Yan H; Xiao F; Zou J; Qiu C; Sun W; Gu M; Zhang L
Int J Oncol; 2018 Feb; 52(2):367-378. PubMed ID: 29207128
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of Clinical Relevance via Telomere Maintenance Mechanism.
Sung JY; Cheong JH
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681758
[TBL] [Abstract][Full Text] [Related]
4. NR4A1 Promotes Diabetic Nephropathy by Activating Mff-Mediated Mitochondrial Fission and Suppressing Parkin-Mediated Mitophagy.
Sheng J; Li H; Dai Q; Lu C; Xu M; Zhang J; Feng J
Cell Physiol Biochem; 2018; 48(4):1675-1693. PubMed ID: 30077998
[TBL] [Abstract][Full Text] [Related]
5. Telomere Maintenance Mechanisms in Cancer.
Gaspar TB; Sá A; Lopes JM; Sobrinho-Simões M; Soares P; Vinagre J
Genes (Basel); 2018 May; 9(5):. PubMed ID: 29751586
[TBL] [Abstract][Full Text] [Related]
6. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
7. Telomere maintenance mechanism dysregulation serves as an early predictor of adjuvant therapy response and a potential therapeutic target in human cancers.
Zhang Y; Luo S; Jia Y; Zhang X
Int J Cancer; 2022 Jul; 151(2):313-327. PubMed ID: 35342938
[TBL] [Abstract][Full Text] [Related]
8. The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival.
Royds JA; Al Nadaf S; Wiles AK; Chen YJ; Ahn A; Shaw A; Bowie S; Lam F; Baguley BC; Braithwaite AW; MacFarlane MR; Hung NA; Slatter TL
PLoS One; 2011; 6(10):e26737. PubMed ID: 22046342
[TBL] [Abstract][Full Text] [Related]
9. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
[TBL] [Abstract][Full Text] [Related]
10. Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
Gocha AR; Nuovo G; Iwenofu OH; Groden J
Am J Pathol; 2013 Jan; 182(1):41-8. PubMed ID: 23260199
[TBL] [Abstract][Full Text] [Related]
11. Telomere Length Maintenance and Its Transcriptional Regulation in Lynch Syndrome and Sporadic Colorectal Carcinoma.
Nersisyan L; Hopp L; Loeffler-Wirth H; Galle J; Loeffler M; Arakelyan A; Binder H
Front Oncol; 2019; 9():1172. PubMed ID: 31750255
[No Abstract] [Full Text] [Related]
12. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
13. Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof.
Claude E; Decottignies A
Curr Opin Genet Dev; 2020 Feb; 60():1-8. PubMed ID: 32114293
[TBL] [Abstract][Full Text] [Related]
14. Telomere Maintenance Pathway Activity Analysis Enables Tissue- and Gene-Level Inferences.
Nersisyan L; Simonyan A; Binder H; Arakelyan A
Front Genet; 2021; 12():662464. PubMed ID: 33897770
[TBL] [Abstract][Full Text] [Related]
15. Alternative Lengthening of Telomeres and Mediated Telomere Synthesis.
Hou K; Yu Y; Li D; Zhang Y; Zhang K; Tong J; Yang K; Jia S
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565323
[TBL] [Abstract][Full Text] [Related]
16. Mitochonic acid-5 attenuates TNF-α-mediated neuronal inflammation via activating Parkin-related mitophagy and augmenting the AMPK-Sirt3 pathways.
Huang D; Liu M; Jiang Y
J Cell Physiol; 2019 Dec; 234(12):22172-22182. PubMed ID: 31062359
[TBL] [Abstract][Full Text] [Related]
17. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity.
Sung JY; Lim HW; Joung JG; Park WY
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784588
[TBL] [Abstract][Full Text] [Related]
19. ALTernative Telomere Maintenance and Cancer.
Dilley RL; Greenberg RA
Trends Cancer; 2015 Oct; 1(2):145-156. PubMed ID: 26645051
[TBL] [Abstract][Full Text] [Related]
20. Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.
Gao J; Pickett HA
Nat Rev Cancer; 2022 Sep; 22(9):515-532. PubMed ID: 35790854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
